CD34+Cell Dose Is the Major Cell Dose Determinant of Myeloid Engraftment After Single Umbilical Cord Blood Transplantation (sUCBT) for Adult Patients with High-Risk Hematologic Malignancies

被引：0
|
作者：
Sanz, Jaime [1 ]
Montesinos, Pau [1 ]
Martinez, David [1 ]
Lorenzo, Ignacio [1 ]
Palau, Javier [1 ]
Larrea, Luis [2 ]
Planelles, Dolores [2 ]
Martin, Guillermo [1 ]
Jarque, Isidro [1 ]
De La Rubia, Javier [1 ]
Moscardo, Federico [1 ]
Martinez, Jesus [1 ]
Angel Sanz, Miguel [1 ]
Sanz, Guillermo F. [1 ]
机构：
[1] Hosp Univ La Fe, Valencia, Spain
[2] Ctr Transfus Comunidad Valenciana, Valencia, Spain
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：574 / 574
页数：1
相关论文
共 50 条
  • [1] A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies
    U Sobol
    A Go
    S Kliethermes
    S Bufalino
    T Rodriguez
    S Smith
    M Parthasarathy
    P Stiff
    [J]. Bone Marrow Transplantation, 2015, 50 : 1519 - 1525
  • [2] A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies
    Sobol, U.
    Go, A.
    Kliethermes, S.
    Bufalino, S.
    Rodriguez, T.
    Smith, S.
    Parthasarathy, M.
    Stiff, P.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 (12) : 1519 - 1525
  • [3] Assessment of CD34+cell viability at thaw/infusion for dual-unit cord blood transplantation: Correlation of viable CD34+cell dose with engraftment
    Vasileiou, S.
    Baltadakis, I.
    Panitsas, F.
    Tzannou, I.
    Poulopoulou, Z.
    Bika, I.
    Papageorgiou, M.
    Karatza, M. -E
    Garofalaki, M.
    Tziotziou, E.
    Bouzani, M.
    Gigantes, S.
    Apostolidis, J.
    Harhalakis, N.
    Karakasis, D.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S353 - S353
  • [4] Total nucleated and CD34 cell dose and their impact on engraftment and NRM after single unrelated cord blood transplantation for patients with haematological malignancies
    Cunha, R.
    Michallet, M.
    Michel, G.
    Socie, G.
    Rio, B.
    Mohty, M.
    Yakoub-Agha, I.
    Sirvent, A.
    Maillard, N.
    Dalle, J. -H.
    Ruggeri, A.
    Gluckman, E.
    Milpied, N.
    Rocha, V.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S11 - S12
  • [5] Double Umbilical Cord Blood Transplantation Offers Stable Donor Engraftment and The Prospect Of Cure In Adult Patients With High-Risk Hematologic Malignancies
    Baltathakis, Ioannis
    Panitsas, Fotios
    Komitopoulou, Anna
    Tzannou, Ifigeneia
    Gigantes, Stavros
    Vasileiou, Spyridoula
    Poulopoulou, Zoi
    Garofalaki, Maria
    Tziotziou, Eirini
    Karatza, Maria-Eleni
    Grispou, Eirini
    Apostolidis, John
    Harhalakis, Nikolaos
    Karakassis, Dimitrios
    [J]. BLOOD, 2013, 122 (21)
  • [6] Association of CD34+Cell Dose with Progression-free Survival after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation in Children with Hematologic Malignancies
    Wang, Yi-Lun
    Chang, Tsung-Yen
    Hsieh, Hsin-Yi
    Chen, Shih-Hsiang
    Wen, Yu-Chuan
    Chiu, Chia-Chi
    Jaing, Tang-Her
    [J]. TRANSPLANTATION PROCEEDINGS, 2023, 55 (02) : 481 - 484
  • [7] Analysis of 402 Cord Blood Units to Assess Factors Influencing Infused Viable CD34+Cell Dose: The Critical Determinant of Engraftment
    Purtill, Duncan
    Smith, Katherine
    Meagher, Richard
    Lubin, Marissa
    Scaradavou, Andromachi
    Stevens, Cladd
    Barker, Juliet N.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S59 - S60
  • [8] Analysis Of 402 Cord Blood Units To Assess Factors Influencing Infused Viable CD34+Cell Dose: The Critical Determinant Of Engraftment
    Purtill, Duncan
    Smith, Katherine M.
    Tonon, Joann
    Evans, Katherine L.
    Lubin, Marissa N.
    Byam, Courtney
    Ponce, Doris M.
    Scaradavou, Andromachi
    Stevens, Cladd E.
    Barker, Juliet N.
    [J]. BLOOD, 2013, 122 (21)
  • [9] Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+cell dose
    Sorigue, Marc
    Sancho, Juan-Manuel
    Morgades, Mireia
    Moreno, Miriam
    Grifols, Juan-Ramon
    Alonso, Eva
    Junca, Jordi
    Ferra, Christelle
    Batlle, Montserrat
    Vives, Susana
    Motllo, Cristina
    Garcia-Caro, Montserrat
    Navarro, Jose-Tomas
    Milla, Fuensanta
    Feliu, Evarist
    Ribera, Josep-Maria
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (04) : 916 - 922
  • [10] Long-term hematopoietic engraftment after autologous peripheral blood progenitor cell transplantation in pediatric patients: Effect of the CD34+cell dose
    Diaz, MA
    Vicent, MG
    Garcia-Sanchez, F
    Vicario, JL
    Madero, L
    [J]. VOX SANGUINIS, 2000, 79 (03) : 145 - 150
12345